Khalid Umar Fakhri

Dr. Khalid Umar Fakhri

Biosciences, Jamia Millia Islamia, New Delhi, India
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2020 in Coatings
Verified
Journal Article
Open access
PDF file
SASultan Alshehri
Sultan Alshehri
Syed Sarim ImamSyed Sarim Imam
Syed Sarim Imam
RIRizwanullah
Rizwanullah
Khalid Umar FakhriKhalid Umar Fakhri
Khalid Umar Fakhri
MRMoshahid Alam Rizvi
Moshahid Alam Rizvi
Mohsin kaziMohsin kazi
Mohsin kazi
In the present study, thymoquinone (TQ)-encapsulated chitosan- (CS)-coated poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles (NPs) were formulated using the emulsion evaporation method. NPs were optimized by using 33-QbD approach for improved efficacy against breast cancer. The optimized thymoquinone loaded chitosan coated Poly (d,l-lactide-co-glycolide) nanoparticles (TQ-CS-PLGA-NPs) were successfully characterized by different in vitro and ex vivo experiments as well as evaluated for cytotoxicity in MDA-MB-231 and MCF-7 cell lines. The surface coating of PLGA-NPs was completed by CS coating and there were no significant changes in particle size and entrapment efficiency (EE) observed. The developed TQ-CS-PLGA-NPs showed particle size, polydispersibility index (PDI), and %EE in the range between 126.03–196.71 nm, 0.118–0.205, and 62.75%–92.17%. The high and prolonged TQ release rate was achieved from TQ-PLGA-NPs and TQ-CS-PLGA-NPs. The optimized TQ-CS-PLGA-NPs showed significantly higher mucoadhesion and intestinal permeation compared to uncoated TQ-PLGA-NPs and TQ suspension. Furthermore, TQ-CS-PLGA-NPs showed statistically enhanced antioxidant potential and cytotoxicity against MDA-MB-231 and MCF-7 cells compared to uncoated TQ-PLGA-NPs and pure TQ. On the basis of the above findings, it may be stated that chitosan-coated TQ-PLGA-NPs represent a great potential for breast cancer management.

22 May 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
Khalid Umar FakhriKhalid Umar Fakhri
Khalid Umar Fakhri
DSDeepti Sharma
Deepti Sharma
HFHoma Fatma
Homa Fatma
DYDurdana Yasin
Durdana Yasin
MAManzar Alam
Manzar Alam
MRMoshahid Alam Rizvi
Moshahid Alam Rizvi
Oxidative stress (OS), resulting from an imbalance between reactive oxygen species (ROS) and the antioxidant defense system, plays a critical role in the initiation and progression of cancer. Recent research has highlighted the regulatory influence of non-coding RNAs (ncRNAs) on cancer initiation and development through the regulation of redox homeostasis and key signaling pathways, which makes them potential targets for anticancer therapy. The ncRNA–oxidative stress axis contributes to malignancy through DNA damage, altered signaling, and dysregulated molecular networks. Plant-derived dietary components and phytochemicals have garnered significant attention for their ability to restore ROS balance and modulate the ncRNA/OS axis, thereby inhibiting carcinogenesis and enhancing the efficacy of chemotherapy. To study the interplay between OS, ncRNAs, and the anticancer potential of plant-derived compounds, in this review, we conducted an extensive search of electronic databases to identify and analyze studies that explore the interwork between OS, ncRNAs, and the chemotherapeutic role of phytochemicals. We discuss the dual role of phytochemicals in both cancer induction and suppression, emphasizing their capacity to generate ROS and regulate ncRNA expression. Furthermore, the review underscores the importance of nutritional interventions and antioxidant regulation in cancer chemoprevention and therapy, including the interconnected roles of oxidative stress, ncRNAs, and phytochemicals in cancer development and treatment, with a focus on dietary modulation as a strategic approach in oncology.

18 June 2024 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
KIKhalid Imtiyaz
Khalid Imtiyaz
MSMohsin Shafi
Mohsin Shafi
Khalid Umar FakhriKhalid Umar Fakhri
Khalid Umar Fakhri
LULaraib Uroog
Laraib Uroog
BZBushra Zeya
Bushra Zeya
MRMoshahid Alam Rizvi
Moshahid Alam Rizvi
Cancer poses a significant global health challenge, contributing to substantial mortality rates and driving the urgent need for exploration into bioactive compounds with potent anticancer properties. Polydatin (PD), a stilbenoid compound abundant in various fruits and vegetables, has emerged as a promising candidate in cancer research. Renowned in traditional Chinese medicine for its multifaceted biological activities encompassing antioxidant, anti-inflammatory, anticancer, hepatoprotective, neuroprotective, and immunostimulatory effects, PD stands out as a versatile therapeutic agent. This review paper meticulously compiles the diverse anticancer attributes of polydatin across a spectrum of cancer types, elucidating its impact on pivotal cancer hallmarks such as proliferation, migration, metastasis, apoptosis, modulation of the tumour microenvironment, autophagy, and more. Furthermore, the review intricately explores the intricate pathways influenced by polydatin within cancer cells, unveiling its mechanisms of action and identifying potential therapeutic targets. By providing a comprehensive analysis of how polydatin affects various facets of cancer progression and addresses treatment resistance, this paper aims to enhance our understanding of its pivotal role in cancer therapy. Moreover, the synergistic potential of polydatin in combination with other drugs is investigated to underscore its amplified efficacy in combating cancer through innovative mechanism-based strategies. The synthesis of these insights underscores polydatin's significance as a valuable component in the advancement of novel approaches to cancer prevention and treatment. This review aims to comprehensively compile and analyze the diverse anticancer attributes of polydatin (PD) across various cancer types, elucidating its impact on pivotal cancer hallmarks such as proliferation, migration, metastasis, apoptosis, and modulation of the tumour microenvironment. Additionally, it explores the intricate pathways influenced by polydatin within cancer cells, unveiling its mechanisms of action and identifying potential therapeutic targets. Moreover, the review investigates polydatin's potential synergistic effects with other anticancer drugs, while also examining its therapeutic and preventive effects against various cancers. A systematic review of scientific literature, comprising research articles, clinical trials, and reviews, was conducted to analyze polydatin's anticancer properties. Reputable databases like PubMed, ScienceDirect, and Google Scholar were searched, and selected studies were critically evaluated to extract essential insights into polydatin's mechanisms of action and its interactions with other anticancer drugs, utilizing keywords targeting specific cancer types such as colorectal, oral, breast, and cervical cancer. The review and additional online research on polydatin reveal that it exhibits multifaceted biological activities, including antioxidant, anti-inflammatory, and anticancer effects. Across various cancer types, polydatin demonstrates promising properties, impacting key cancer hallmarks such as proliferation and metastasis. These findings underscore polydatin's diverse therapeutic potential, particularly in cancer treatment, by targeting crucial pathways involved in cancer progression and offering insights into its mechanisms of action. Polydatin shows potential as a valuable component in cancer therapy, addressing various facets of cancer progression and treatment resistance. Synergistic potential with other drugs suggests amplified efficacy in combating cancer through innovative mechanism-based strategies. The review underscores the significance of polydatin in the advancement of novel approaches for cancer prevention and treatment.

2 August 2025 in The Microbe
Verified
Journal Article
Open access
SKShabana Khatoon
Shabana Khatoon
NRNafis Raj
Nafis Raj
Khalid Umar FakhriKhalid Umar Fakhri
Khalid Umar Fakhri
Sugandh KumarSugandh Kumar
Sugandh Kumar
NMNikhat Manzoor
Nikhat Manzoor

23 July 2024
Verified
Book Chapter
Closed access
PDF file
GAGarima
Garima
KIKhalid Imtiyaz
Khalid Imtiyaz
POPooja
Pooja
PPPrachi Pannu
Prachi Pannu
ASAnjali Sharma
Anjali Sharma
AMAnil Kumar Mavi
Anil Kumar Mavi

1 January 2021
Verified
Book Chapter
Closed access
Khalid Umar FakhriKhalid Umar Fakhri
Khalid Umar Fakhri
BABader Saud Alotaibi
Bader Saud Alotaibi
SKSumit Kumar
Sumit Kumar
UKUmesh Kumar
Umesh Kumar
Subash Chandra SonkarSubash Chandra Sonkar
Subash Chandra Sonkar
MRM. Moshahid Alam Rizvi
M. Moshahid Alam Rizvi
Several modern treatment procedures have been received to battle malignancy with the point of limiting lethality. Phytopharmaceuticals are auxiliary metabolites of plant origin which exclusively contain one or more substances as active ingredients or might be a blend of them. Analysts have excitedly attempted to diminish the lethality of current chemotherapeutic agents either by consolidating them with herbals or in utilizing herbals alone. Synergy is a procedure where a few substances participate to reach a consolidated impact that is more prominent than the entirety of their different impacts. It may be viewed as a characteristic straight technique that has developed ordinarily by nature to acquire more efficacies at a low cost. This chapter aims to present the fundamental mechanism of the activity of phytochemicals in combination therapy. This chapter additionally features the remarkable synergistic impacts of plant-drug cooperation with an emphasis on anticancer strategies.